159 related articles for article (PubMed ID: 27093735)
21. Neuroleptic-induced catalepsy: a D2 blockade phenomenon?
Klemm WR
Pharmacol Biochem Behav; 1985 Dec; 23(6):911-5. PubMed ID: 2867564
[TBL] [Abstract][Full Text] [Related]
22. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
[TBL] [Abstract][Full Text] [Related]
23. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
Zharkovskiĭ AM; Matvienko OA; Nurk AM
Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
[TBL] [Abstract][Full Text] [Related]
24. Antagonism of apomorphine-induced cage climbing behaviour and methamphetamine stereotypy by fenfluramine in mice.
Gada VP; Joshi VV; Balsara JJ; Chandorkar AG
Indian J Physiol Pharmacol; 1984; 28(4):326-30. PubMed ID: 6543532
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of haloperidol-induced catalepsy by dopamine agonists: possible involvement of central 5-hydroxytryptamine.
Carter CJ; Pycock CJ
Pharmacol Biochem Behav; 1979 Apr; 10(4):475-80. PubMed ID: 572550
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
[TBL] [Abstract][Full Text] [Related]
27. Effect of pre-treatment of some calcium channel blockers on catalepsy and stereotypic behaviour in rats.
Khanzode SD; Mahakalkar SM; Belorkar NR; Kharkar VT; Manekar MS
Indian J Physiol Pharmacol; 1996 Apr; 40(2):159-62. PubMed ID: 9062812
[TBL] [Abstract][Full Text] [Related]
28. Experimental catalepsy is both enhanced and disrupted by apomorphine.
Klemm WR
Psychopharmacology (Berl); 1985; 87(1):12-5. PubMed ID: 3933030
[TBL] [Abstract][Full Text] [Related]
29. L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum.
Lee J; Rushlow WJ; Rajakumar N
Neuroscience; 2007 Nov; 149(3):602-16. PubMed ID: 17913375
[TBL] [Abstract][Full Text] [Related]
30. Serotonergic involvement in haloperidol-induced catalepsy.
Neal-Beliveau BS; Joyce JN; Lucki I
J Pharmacol Exp Ther; 1993 Apr; 265(1):207-17. PubMed ID: 8386235
[TBL] [Abstract][Full Text] [Related]
31. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
Jeziorski M; White FJ
Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
[TBL] [Abstract][Full Text] [Related]
32. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
[TBL] [Abstract][Full Text] [Related]
33. Effects of raclopride on exploratory locomotor activity, treadmill locomotion, conditioned avoidance behaviour and catalepsy in rats: behavioural profile comparisons between raclopride, haloperidol and preclamol.
Hillegaart V; Ahlenius S
Pharmacol Toxicol; 1987 May; 60(5):350-4. PubMed ID: 3615345
[TBL] [Abstract][Full Text] [Related]
34. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
[TBL] [Abstract][Full Text] [Related]
35. Study of the participation of the dopaminergic transmission system in the effects of two newly synthesized barbiturates.
Getova D; Markovska V
Acta Physiol Pharmacol Bulg; 1988; 14(2):56-62. PubMed ID: 2851915
[TBL] [Abstract][Full Text] [Related]
36. Some behavioural effects of chloroquine in rats suggesting dopaminergic activation.
Amabeoku GJ
Indian J Med Res; 1994 Feb; 99():87-94. PubMed ID: 8005645
[TBL] [Abstract][Full Text] [Related]
37. Catalepsy induced by morphine or haloperidol: effects of apomorphine and anticholinergic drugs.
Erzin-Waters C; Muller P; Seeman P
Can J Physiol Pharmacol; 1976 Aug; 54(4):516-9. PubMed ID: 10058
[TBL] [Abstract][Full Text] [Related]
38. A role for presynaptic mechanisms in the actions of nomifensine and haloperidol.
Garris PA; Budygin EA; Phillips PE; Venton BJ; Robinson DL; Bergstrom BP; Rebec GV; Wightman RM
Neuroscience; 2003; 118(3):819-29. PubMed ID: 12710989
[TBL] [Abstract][Full Text] [Related]
39. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
Banasikowski TJ; Beninger RJ
Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
[TBL] [Abstract][Full Text] [Related]
40. Effect of angiotensin on the central action of dopamine.
Braszko J; Wiśniewski K
Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
